PEMBROLIZUMAB
Clinical trials for PEMBROLIZUMAB explained in plain language.
Never miss a new study
Get alerted when new PEMBROLIZUMAB trials appear
Sign up with your email to follow new studies for PEMBROLIZUMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo aims to halt rare sarcomas
Disease control Recruiting nowThis study tests whether two drugs, zanzalintinib and pembrolizumab, can help control advanced soft-tissue sarcoma that has spread. About 20 adults with specific sarcoma types will receive the combination. The main goal is to check safety and see if the treatment slows tumor grow…
Matched conditions: PEMBROLIZUMAB
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New cocktail of chemo, immunotherapy, and bladder drug takes on recurrent ovarian cancer
Disease control Recruiting nowThis phase 2 trial is testing whether a combination of two chemotherapy drugs (paclitaxel or nab-paclitaxel), an immunotherapy (pembrolizumab), and a bladder drug (mirabegron) can shrink tumors in people with ovarian cancer that has come back after initial treatment. About 20 adu…
Matched conditions: PEMBROLIZUMAB
Phase: PHASE2 • Sponsor: Obstetrics & Gynecology Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC